Laboratory Findings by Büttner, J.
Büttner: Laboratory findings in mcdical cognitive proccsscs 507
Eur. J. Clin. Chem. Clin. Biochem*
Vol. 29, 1991, pp. 507-519
© 1991 Walter de Gruyter & Co.
Berlin · New York
Laboratory Findings:
Structure, Validity and Significance for Medical Cognitive Processes1)
By J. Büttner
Institut für Klinische Chemie lim Zentrum Laboratoriumsmedizin, Medizinische Hochschule, Hannover, Germany
(Received April 15/May 21, 1991)
Summary: Modern medicine employs laboratory findings to a great extent in medical cognitive and decision
processes. As supposedly "hard" data, the value of such findings is frequently incorrectly assessed. So far, no
comprehensive general theory of laboratory findings has been available, although various subproblems have
been dealt with. Firstly, the structure of a laboratory finding will be investigated in detail, proceeding from
an analysis of the scientific language used for laboratory findings. The part played by laboratory findings in
medical cognitive processes in making a diagnosis or prognosis will then be shown. Finally, attempts at
characterizing the validity of a laboratory finding with the aid of statistical methods and Information theory,
äs well äs appropriate Steps for checking the validity will be discussed.
Introduction
Laboratory findings are the product of work in the
laboratory. In medicine, they are obtained daily in
great numbers and employed by the physician in bis
practical activity at the sick-bed. The clinical chemist
or laboratory physician compiling the laboratory find-
ings is aware of the analytical errors which can falsify
the findings; the physician at the sick-bed tends how-
ever to believe them to be "hard data". Both however
consider laboratory findings to be empirical data es-
sential in medical work. So far, not very much atten-
tion has been paid to the theoretical processes in the
formation and evaluation öf laboratory findings. In
other words, laboratory findings have so far not been
investigated from the Standpoint pf philosophy of
science. Below, an attempt will be made at such an
analysis. For this purpose, the laboratory finding
must be seen in a larger context. The conceptual and
methodic instrumentarium of clinical chemistry,
biometry and informatics does not suffice; it must be
amplified by drawing on other faculties, for instance
analytical philosophy and semiotics (1).
Based on a lecture at the Heidelberg Colloquium of Medical
Biometry, Informatics and Epidemiology, 21. 1. 1991.
Structure of a Laboratory Finding: Syntactics
In order to analyse the linguistic and notional struc-
ture of a laboratory finding, we shall proceed from a
simple example. The essence of a laboratory finding
is the description of an object property, in the simple
example of table l a property of a specific urine. It






is characteristic of a laboratory finding to be the result
of a scientific experiment, for instance a chemical
analysis. In this paper, to simplify matters, we shall
disregard the analytical chemical problems which are
very important in practice and which can prevent
exact acquisition of the object property sought. For
setting forth the results of a laboratory investigation
it will be expedient not to use colloquial language but
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to employ a more highly formalised "scientific lan-
guage" (2). The sentences in which this is done are
referred to äs "observation sentences" or "prolocol
sentences", for instance: ''The specimen ofpatient y
had t he proper t y z at the time t". Such a sentence is
the mental reflection of a fact, in our case an object
property. The essence of the Statement can be ex-
pressed in the language of mathematical logic in sam-
ple manner by a predicate variable G and an individ-
ual variable u. If the predicate variable G means
"contains glucose" and the individual variable u means
a specific urine, then we can express the observation
"urine u contains glucose" äs G u. However, the rela-
tionships are usually more complex, in that the orig-
inal observation is "transformed" to the final result
by one or more conclusions. In the simple example
of urine examination for glucose, the immediate ob-
servation is a change in colour. On the basis of existing
knowledge of the analysis method applied, it is pos-
sible to derive from this the Statement that the urine
contains glucose. For this derivation of one sentence
from another, a transformation rule is necessary. The
procedure which can be adopted here is the scheine
of the "modus ponens" of classical logic (3). This
requires a general regularity, for example a "if-then
implication", expressing general knowledge on the
analysis method employed. In the case of our simple
example this implication could read: "z7 is truefor all
individuals that: if colouring occurs then glucose is
present". Or, using the notation of mathematical logic
/\x [C => G x]
The symbol denotes the all-operator ("for all
... is true"). The predicates denote: C "colouring", G
"glucose". The individual variable means "analysis
sample".
From this regularity the conclusion G u can be de-
rived, which is the actual Statement of the laboratory






explanation which was investigated in particular by
Hempel and Oppenheim (4, 5) (see below for more
details).
The efficiency of a language in representing object
properties increases if adjectives (for example "red",
"cloudy") or numbers are lised. In a scientific lan-
guage of the type we use for laboratory findings, by
metrisation (tab. 2) a gfeater precision of the scientific
Statement can be achieved (6). Metrisation does not







































(The individual variable u Stands for a specific urine).
With complicated analysis methods the transforma-
tion rule often contains several implications in succes-
sion. The procedure for deriving the transformation
rule corresponds to the general scheme of a scientific
all that is changed is our System of concepts, i. e. the
language in which we express our finding. In the
simplest case, the object properties are classißed on
the basis of specific qualitative charaeteristics. The
fundamental Operation is the determination of the
identity of the object property with the property of a
defined class. Where possible, a simple comparison
method for the respective object property can be
developed which permits the determination of rela-
tionships, for example "greater or smaller than". This
comparison is the next step of metrisation. The highest
degree of metrisation is achieved by devising a quan-
titative method, i. e. by a measurement in the trüe
sense. This is called quantification. Thereby it is pos*
sible to assign numbers to the object property. This
is frequently done by determining a ratio, for example
the measurement result for the object to be examined
related to that of an exactly measured reference ma-
terial.
The introduction of metrical concepts requires exact
definition of a quantity for the object property and
the creation of suitable scales (7> 8). In table 3 the
definition of a quantity in clinical chemistry will be
explained. By international agreement, a quantity is
represented by the elements "System" (investigated
material), "analyte" (component to be determined),
"kind of quantity" (e. g. subsftance concentration) and
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 29,1991 / No. 8
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Tab. 3. Definition of a clinical chemical quantity
A clinical chemical quantity consists of the following elements:








Serum — potassium, amount of substance concentration,
4.6 mmol/1
"unit" (e. g. mmol/1). The choice of the kind of quan-
tity governs the nature of the scale and the unit defines
the scale exactly (9, 10). For a typical example of the
Problems which may arise in setting up a metrical
System for a chemical analysis, a recent paper on
measurement of biological substances by means of
immunoassays (11) should be consulted.
Usually, laboratory findings äs a description of an
object property are not stationary quantities inde-
pendent of time. For this reason, a general conceptual
definition of the laboratory finding must also contain
the dimension time. Theoretical models to describe
the time dependence of laboratory findings can be
very complex. Attention will be drawn here only to
the simple possibility of describing the time profile of
laboratory findings in a pathological process äs a
Markov chain (12). The typical course of a disease,
e. g. of a certain carcinoma, can be described by a
number of states or stages I, II, III ... The transition
from one stage to another, e. g. I —> II, may be char-
acterized by the conditional probability P (I | II). The
Markov graph contains all of the transitions and their
probabilities. In figure l the stages of the prostatic
cancer are defined by the outcome of enzyme deter-
minations, e. g. "alkaline phosphatase non-pathologi-
cal" and "acid phosphatase pathologicar. The num-
bers denote the conditional probabilities (taken from
I.e. (13)).
It is apparent from this short consideration of the
structure of laboratory findings that the latter repre-
sent observation sentences obtained from an experi-
ment. Various rules must be followed in order to
represent correctly these observation sentences and
the propositions derived from them. It must be en-
sured that the laboratory findings are "syntactically
well formed observation sentences".
Significance of a Laboratory Finding: Semantics
In the analysis of the linguistic and theoretical struc-
ture of laboratory findings, the "content" or the
"meaning" of a laboratory finding have so far been
disregarded. The physician at the sick-bed wishing to
employ the laboratory findings is not interested in
their structure. He wants to know their "meaning".
The "meaning" of a laboratory finding can be differ-
ent depending on the medical use. Therefore it appears
advisable to take a short look at the medical uses
made of laboratory findings before investigating the
term "meaning" (tab. 4).
0.48 0.41
Fig. l. Markov model of prostatic cancer.
Explanation: AP = alkaline phosphatase not elevated,
AP = alkaline phoaphatase elevated, ÄcP = acid phos-
phatase not elevated, AcP = acid phosphatase elevated.
Numbers denote transition probabilities.
From Meyers et at. (13).
Tab. 4. Medical use of laboratory findings
Diagostic use
Classificatioö of disease
Determination of etiology and patho-mechanism
Examination of the state of the patient
Searching for risk factors
Prognostic use
Prognosis with respect to exit (death, eure)
Prognosis with respect to course
Prognosis with respect to risk of therapy
Prognosis with respect to future diseases
Use in connection with therapeutic measures
Selection and control of efficiency of therapeutic measures
What is the "meaning" of a laboratory finding? How
in fact does the finding obtain its meaning at all? The
Instruments of modern semiotics, the theory of signs,
are a great help in answering these questions (for
more Information about semiotics see for example:
o. c. (14 — 19)). Just like clinical Symptoms, laboratory
Bur. J. Clin. Chem.Clin. Biochem. / Vol. 29,1991' / No. 8
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findings are signs, i.e. phenomena standingfor some-
thing eise. These signs stand for a disease; they indicate
a disease.
In semiotics a distinction is made (20) between the
sign, i. e. the phenomenon observed, and the signifi-
catum, i. e. what the sign indicates or what it "signi-
fies". The significatum is a concept, that is a mental
construct, existing only in the interpreting mind of
the physician. In many cases the significatum relates
to a concrete object. For this, the term denotatum is
used. The sign, significatum and denotatum are qften
expressed in their mutual relationships in the form of
the "Baldinger Triangle" (21) which is shown in figure
2, using the example of a "diagnostic sign".
Now, how is a meaning allocated to a sign? This
Operation is called "process of signification" or "se-
miosis". Charles Morris (22), one of the founders of
semiotics, distinguished between three subareas of
semiotics and introduced for them the terms "syntac-
tics", "semantics" and "pragmatics". Syntactics inves-
tigate the structure and mutual relationship of signs,
i. e. the topic discussed above. Semantics on the other
band relate to the relationship of a sign and its sig-
nificatum or denotatum. Finally, pragmatics investi-
gate the use of the sign by the user.
Below, the process of signification for a laboratory
finding will be set forth in somewhat more detail. We
take äs an example a clinical chemical finding which
is used for diagnostic purposes. The process of sig-
nification takes place in stages and a distinction can
be made between three levels; these will be denoted
"technical level", "biological level" and "nosological
level" (fig. 3).
As explained above, on the technical level the
"syntactically well formed" observation sentence de-
scribing an object or material property is developed.
On the biological level, different classifications
take place which are referred to in clinical chemistry
äs "longitudinal evaluation" and "transversal evalu-











Fig. 2. Laboratory finding äs a medical sign.
ation" (23, 24). The former investigates the relation-
ship of an actual finding to the preeeding findings for
the same patient, i. e. the change with time. In the
transversal evaluation, on the other band, the actual
finding is compared with a reference population. This
gives the individual laboratory finding the meaning
of'pothological" or "non-pathological". The reference
population, for example a population of clinically
healthy persons, must be defined by suitable external
criteria. The transversal evaluation takes place by
means of a reference interval which is defined äs the
central 0.95 fraction of the values of the reference
population (25).
On the third level, the nosological level, the sign
is allocated to the significatum, i. e. the disease. Here,
an interesting change has taken place in the course of
the history of medicine (for a discussipn of the his-
torical development of "chemical signs" in medicine
see L c. (26)). Originally, a series of empirically ob-
tained signs was simply given the name of a disease.
The sign was used without any causal explaiiation äs
"indication" of a disease. This method, first used by
Hippocrates, could be called the "syntactic" method
(27); the sign pattern is allocated to a disease name.
Modern attempts at computer-aided diagüosis fre-
quently employ the same principle. With increasing
knowledge, a Start has been made at explaining the
signs observed on the basis of a theory of the disease.
This is the "semantic" method, the beginnings of
which can be traced back to Galen but which was not
fully developed until the scientific medicine of the
19th Century. The sema:ntic method requires the def-







Fig. 3. Signification process for ä laboratory finding.
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is the term used when etiology and pathogenesis are
known and uniform. If either the etiology or the
pathogenesis or both are not clear or not uniform,
the term "syndrome" is used (28). The allocation of a
sign requires the "causal" explanation of the sign
based on the pathogenesis of the morbus. It is only a
sign interpreted in this manner which can be regarded
äs of füll diagnostic value. Now, what is the "causal"
explanation of a laboratory finding? A simple example
will be taken: The leading laboratory findings in Gal-
actosaemia are the elevated concentration of galactose
in blood and the excretion of galactose in urine (gal-
actosuria). This is explained by the genetically induced
absence of the enzyme, galactose-1-phosphate uridyl
transferase, which can be demonstrated in erythro-
cytes. This type of "inborn error of melabolism" (A.
E. Garrod) with a monogenetic defect shows a very
clear relation between "cause" and "sign".
An important Step in the process of signification for
a diagnostically used laboratory finding is therefore
the explanation of the finding on the basis of the
pathogenesis of the morbus. What however does "ex-
planation" mean? The cognitive process on which a
scientific explanation is based may be explicated äs
follows (29 — 31): a process or a phenomenon is to be
explained which is described by an observation State-
ment. For the explanation, universally valid laws L
and antecedence conditions (specific marginal condi-
tions) A are required. These two together form the
so-called explanans.
Explanans
universally valid laws Ll5 L2, L3 ...
antecedence conditions AI, A2, A3 ...
Explanaiiduiii propositiön E
The explanation consists in deductively deriving a
Statement or proposition äs explanandum from the
explanans. This is the so called deductive-nomological
scheme. (DN scheme) of the explanation developedby
Hempel & Oppenheim (32).
The example discussed above may be represented
follows usiiig this scheme:
Example: Galactosaemia
L: f\x[-}Tx=> Hx U ]
A: -
äs












In medicine, universal laws are rather the exception.
This is due to the great complexity of biological
Systems and the methodical uncertainty resulting from
that. In addition, äs we know today, certain laws in
the molecular ränge are of an irreducible statistical
nature. Pathophysiological or pathobiochemical max-
ims which we use for explanations are therefore fre-
quently only Statements of probability. A simple ex-
ample will make this clear: It is known from empirical
investigations that with patients displaying an increase
in the glucose concentration in the blood after stand-
ardized administration of glucose, the metabolism of
glucose is frequently but not always impaired. In a
specific case a causal relationship may be assumed
but not proved with certainty, because the System of
homoeostatic regulation of glucose is very complex.
In such a case the previously discussed DN scheme
of the explanation based on classical logic cannot be
applied. Instead, Hempel & Oppenheim have proposed
the scheme of "inductive-statistical explanation" (IS
explanation) (33).
Premises
statistical "laws" Sl5 S2, S3 ...
antecedence conditions AI, A2, A3 ...
support
Conclusion proposition E
Because of various epistemological difficulties pre-
sented by this concept, Stegmüller (34) prefers the
weaker term "inductive-statistical substantiation"
("Begründung"). The decisive point is that a universal
law is replaced by a probability Statement. It is then
however no longer possible to deduce logically an
explanandum äs in the DN explanation. Instead of
this, the "degree of conflrmation" is given with which
a proposition is supported by the available knowledge
contained in the premise. As is known, Carnap (35)
expressed this "degree of confirmation" äs "inductive
probabilily" or "probability^. In contrast to the DN
explanation, the substantiation by the IS scheme re-
quires the exact specification of the statistical "laws"
employed. This means that the knowledge basis on
which these "laws" are based must be exactly defmed.
Also, the conclusion of an IS substantiation cannot
be formulated äs a modal Statement (e. g. "very prob-
able", "less probable", etc.), because these expressions
say something about the relationship of the premises
Eur. J. Clin. Chenu Clin. Biochem. / Vol. 29,1991 / No. 8
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to the conclusion but are not themselves part of the
conclusion. These restrictions can result in consider-
able problems in the practical application, especially
in the development and use of expert Systems.






Explanation: Degree of confirmation
= probability#
A = assimilation of glticose im-
paired
G = glucose concentration in blood
elevated after standardized
administration of glucose
• a = patient y
As a result of our explication of the meanirig of a
laboratory finding we can state: The laboratory find-
ing obtains its meaning, i. e. its significatum äs sign
of a disease, through a complicated multistage process
of signification. The aim is the explanation on the
basis of the pathogenesis of the morbus concerned.
Explanation in the strict sense is a deductive process.
In medicine, it is frequently replaced by the weaker
inductive-statistical substantiation.
The Diagnostic Process
Just like other medical signs and Symptoms, labora-
tory fmdings are processed at the sick-bed in special
medical cognitive processes·. Such cognitive processes
are for instance the compiling of a diagnosis or pös-
tulation of a prognosis. Diagnosis and prognosis are
in turn again the starting point or "indication" for
action (36) on the part of the physician (for the theory
of diagnosis see for example: o.e., I.e. (37—42)).
The basic process of making a diagnosis may be
described äs a classification. On the basis of a mul-
tidimensional finding vector the disease of a patient
is classified äs a certain morbus (or äs a certain
syndrome). Corresponding theoretical inodels have
been developed in particular in conjunctioti with
"computer-aided-diagnosis". It would be going too
far to discuss this in detail here (for literature sum-
mary see 1. c. (43)).
The cognitive processes in making a diagnosis are
very complex. Hanmann once said: "Medical thinking
is äs a rule a search process, attempt, dismissal, as-
sumption and confirmation" (44). The diagnostic proc-
ess thus cannot be fully described by a simple model.
In addition, there is the uncertainty about the concept
of diagnosis itself. The classieal diagnosis concept of
scientific medicine is relativated in its significance by
the current discussion on the 'philosophy of science.
Also, today in practical medicine the diagnosis process
is frequently only carried on until clear therapeutical
alternatives become apparent.
In our context, the question which interests us most
is at what point of the diagiiostic process laboratory
findings can be used. This can be illustrated very
clearly using a two-stage scheme developed by Me*
dawar (45, 46) and referred to äs a "hypothetico-
deductive scheme" (fig. 4). In the first phase, which
we shall refer to äs "hypothesis formation", ä tentative
diagnosis is made. For this phase, which generally
takes place in stages, no strict logicäl fules apply. The
physician attempts to combine the Symptoms ob-
served and the findings of the concrete case in an
assumed or tentative diagnosis. In this phase, labo*
ratory findings provide more or less concrete iiidica-
tions. The hypothesis formation is carried on against
the background of the clinical experience of the phy-
sician. Of great importance is the subjective or objec-
tive probability assumed for the occurrence of the
suspected disease. For example the tentative diagnosis
"virus influenza" will be influenced by current Infor-
mation on an influenza epidemy. From the semiotic
point of view, in forming the hypothesis the signifi-
catum, i. e. the disease, is deduced from the sign. The
sign is used "semiotically'V
The second phase is the confirmation ofthe hypothesis
formed. For this phase, the strict rules of logicäl
deduction apply. The confinnation of the tentative
diagnosis may be formulated äs explanation.
universally valid laws LI, L2, L3 ...
Symptoms, sings and
findings in the clinical
Explanans Picture
antecedens cönditiöns AI, A2, A3 ...
diagnosis for patient y
Explanandum Symptoms, signs and E
findings for the
patient y
Example (according to Wieland (47)):
L: If acute glömeFulonephritis, then haematuria,
oedema, hypertension, proteinuria
A: patient y has aeute glomerulonephritis
E: Patient y exhibits haematuria, oedema, hyperten-
sion, proteiBuria v *
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Collection of further findings to verify
ttie tentative diagnosis
i
Explanation of all Symptoms, signs,











Fig. 4. Diagnostic process äs hypothetico-deductive scheine.
However, äs Wieland has pointed out (48), it must be
remembered that medical diagnoses, in contrast to
scientific explanations, are Singular Statements which
relate only to a specific patient. Thus, the Symptoms
and findings of this patient are explained from the
knowledge of the morbus and the tentative diagnosis
made in the first phase. In other words, the concept
of the disease is assigned to the iliness of this patient.
By the way, the restrictions already discussed apply
to the deductive phase of the diagnostic process if
statistical "laws" are employed in the explanans, äs is
the rule in medicine. From the semiotic point of view,
in the deductive phase a conclusion is drawn from the
designatum, the disease of a certaiii patient, to the
sign; the sign is employed "nosologically".
This brief outline of the diagnostic process will have
to suffice here. This is not the place to go into details,
in particular the important problem of differential
diagnosis.
The Prognostic Process
Let us now briefly consider the making of a prognosis,
which is based on a very different question compared
with the diagnosis (49). The physician attempts to
make a prediction on the outcoine or course of a
disease for a certain patient.. The prognosis, which in
medicine in preViöüs centuries attained a greater sig-
nificanee than the diagnosis, has only recently received
increased attention again, for example in chronic dis-
eases or in intensive care medicine, where prognostic
conclusions regarding the acute danger are an urgent
necessity without previpusly making a diagnosis. De-
cision on high-risk therapeutical measures (e. g. trans-
plants) also requires prognostic Statements, either to
make decisions or to evaluate Steps taken.
From the logical point of view, today a prognosis is
dealt with in the same manner äs the explanation
already repeatedly mentioned: from laws and actual
antecedence conditions (here also referred to äs "slart-
ing point") the "end point" of the prognosis is deduc-
tively concluded.
Explanans
universally valid Ll5 L2, L3 .
"laws"
antecedens AI, A2, A3
conditions
"starting points of the
prognosis"
Explanandum prognosis P
"end point of the
prognosis"
In a manner very similar to the Situation for a diag-
nosis, the "laws" available for prognoses are of a
mainly statistical nature. Further characteristic of
prognoses is that frequently, although not always, the
dimension of time is contained in the laws used.
A simple example will be considered (according to
Pui et al. (50)): In children with acute lymphatic
leukaemia the level of serum lactate dehydrogenase
(S-LDH) will be elevated before treatment if the sur-
vival time is short. This can be formulated äs a "sta-
tistical law". Now we consider a case of a child y
with acute lymphatic leukaemia having elevated
serum lactate dehydrogenase. From the two premises
the "end point" of the prognosis is derived and in our
example this is for instance a Statement how many
yeafs the patient will survive:
L: Survival time dependent on S-LDH-activity before
treatment
A; Actual activity of S-LDH in patient y
P: Probability Statement on survival time of patient y
Validity of Laboratory Findings
Laboratory findings are the result of a scientific ex-
periment. In hospitals and clinics this has given them
the reputation of "hafd data". A more exact exami-
nation shows, however, that it is possible for labora-
tory findings to embody considerable uncertainties.
These uncertainties influence the medical cognitive
processes discussed and lead to incorrect conclusions.
In practice, this raises the question of the validity of
laboratory findings (51-53). Here, a ''valid labora-
toryfinding" will be considered quite generally to be
a result which correctly answers the question put by
the physician.
Eur. J. Clin. Chen*. Clin. Biochem. / Vol. 29,1991 / No. 8
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Fig. 5. Uncertainty of laboratory fmdings.
To analyse the validity of laboratory findings (fig. 5)
the three-stage scheine already employed when dis-
cussing the process of signification (cf. fig. 3) will be
taken äs a basis. On the technical level the analysis
result is obtained. This is where the errors due to the
analytical methods occur. On the biological level, the
finding is derived from the analysis result. Here, in
particular the biological variance of the quantity in-
vestigated leads to uncertainties. Finally, on the no-
sological level, where the interpretedfinding is formed,
uncertainties arise from the defmition of the morbus
and the inadequate or incorrect pathophysiological
explanation; however, uncertainties also arise due to
the different intensity of the signs and their ambiguity.
Thus, a valid laboratory finding must
(1) correctly describe the property intended to be
measured,
(2) be correctly assessed on the biological level, and
(3) properly assigned to a morbus or syndrome.
This great variety of influences and uncertainties
makes it necessary to develop measures suitable for
the checking and assurance of the validity of the
laboratory findings on all levels of the signification
process. These may be measures for generally testing
("evaluating") the examination method and monitor-
ing it. However, methods for validating the individual
finding of a specific patient are also required.
Errors which occur in compiling laboratory findings
on the technical level, the "analysis errors", can
be described very well by an additive model (fig. 6)
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Fig. 6. Analytical error öf clinicäl chemical analyses.
sophisticated statistical control methods have been
developed which are employed generally today äs
"statistical quality control" (55-57). It is more diffi-
cult to detect the errors in the pfeänalytic phase, i. e.
during the preparation before the actual analysis (58).
Examples are the errors that occur when taking a
blood sample or due to incorrect storage of the sam-
ple. One possibility of detectiüg such errors is pro^
vided by the methods of "plausibility control" (59, 60).
Here, the individual laboratory finding is checked by
comparispn with a large data base.
The cause of uncertainties of laboratory findings on
the biological level is biological Variation. Their
determination and the estimation of their influence
on the validity of a laboratory finding is a classical
problem in biometry. Tfre uncertainties due to bio-
logical Variation have considerable effects on the Ion-
gitudinal evaluation and transversal evaluation, those
two operations in compiling a laboratory finding
which we have already discussed in connection with
the process of signification.
What possibilities do we have for improving the va-
lidity of laboratory findings on the biological level in
view of the fact of biological Variation? By statistical
analysis of suitable data material, it is possible to
identify for a quantity a number öf factors which are
referred to äs "biological influence quantities"
(61-65).
The Variation of laboratory findings may be described
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The intra-individual variance | and the inter-indi-
vidual variance | are decisively governed by the
biological influence quantities. This may for example
be a genetically induced influence or physical activity
or the intake of certain substances with food, such äs
fat or toxic substances in tobacco, alcohol, coffee etc.
Some of the biological influence quantities depend on
time, such äs aging or certain biorhythms. The ahn is
to detect all these influence quantities and take ac-
count of them when examining a patient, standard-
izing them whenever possible. Thus, the old rule of
the clinician of taking blood samples for clinical chem-
ical investigations in the morning from a fasting pa-
tient leads to such a standardization. The concept of
the biological influence quantity also has conse-
quences regarding the correct determination of ref-
erence values äs required for transversal evaluation.
It is essential to select the reference persons carefully
and standardize any possible biological influence
quantities in the reference population using the same
protocol for testing, which is then applied in the
examination of clinical patients (67).
The greatest uncertainties in laboratory findings are
on the nosological level. We shall discuss this by
taking äs example the Interpretation of a laboratory
finding used for diagnostic purposes. Here, many
causes can be found which result to a particular extent
in uncertainties.
The "nosological uncertainty" arises in the process of
signification of the laboratory finding when the mor-
bus or syndrome, which are of course mental con-
structs, are not clearly defined and delineated with
respect to similar diseases. However, uncertainties
arise for the laboratory finding particularly when the
causäl explanation of the finding based on the patho-
genesis of the morbus has not been unequivocally
proved experimentally.
Another source of uncertaiüty is the ämbiguity of the
findings. The ideal diagnostic sign is "pathognomonic",
i. e. it occurs only in a very definite disease. Unfor-
tunately, such ideal signs are rather the exception. In
clinical chemistry we find them for instance in genet-
ically induced metabolic disturbances, such äs the
phenylpyruvic oligophrenia: the finding of phenyl-
pyruvic acid passed in the uriiie occürs only in this
disease and is proof of the disease. However, most
findings are equivocal and can be interpreted in var-
ious ways.
The different intensity of the findings in one and the
same disease in particülar leads to uncertainties. For
a clinical chemical finding this may for example be
due to a "pathological" sübstance, such äs a tumour
marker, being produced in different quantities and
consequently detectable in the blood in fluctuating
concentration.
Often related to this is the fourth cause of uncertainty,
the dependence of a finding on time, for example during
the course of a disease. In clinical practice attempts
are made to reduce this uncertainty by defining
"stages" within the course of the disease.
The uncertainties on the nosological level outlined
can greatly mislead the physician at the sick-bed in
his Interpretation of laboratory findings. It is there-
fore absolutely essential to carefully validate labora-
tory investigations before their clinical introduction.
Apart from this general examination of the methods,
an examination and evaluation of the laboratory find-
ings of a specific patient is of course essential in every
case.
How can clinical laboratory examinations or diag-
nostic examination methods in general be assessed äs
regards their diagnostic value? The reason for working
out suitable validation methods was the broad intro-
duction of diagnostic methods for "screening" large
groups of the population in the period following the
Second World War, because here expensive classifi-
cation errors made themselves particularly noticeable.
The basic problem, which we shall refer to äs the
"diagnostic lest problem", is illustrated in figure 7. A
"positive" or "negative" test result is to be used to
make the classification "sick" (or "not healthy") or
"not sick" (or "healthy"). The aim is to find suitable
quantities or "figures of merit" expressing the effi-
ciency of this classification.
It will not be possible to deal systematically here with
the large number of validation methods which have
been described for diagnostic examinations. Attention
is drawn to some general studies (68 — 73), in which




•negative' test event T
Fig. 7. Diagnostic testing problem.
Explanation: D = diseased, D = not diseased,
T = test result positive, T = test result negative.
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these methods are critically explained. Here, three
such validation methods will be briefly cönsidered
exemplarily.
The classic method originates from a paper by Yerush-
almy in 1947 (74), and is explained in figure 8. It is
the simple case of a qualitative examination with
dichotomic outcome ("pathological", "not patholog-
ical"). Examples are the detection methods for protein
or glucose in urine. To characterize the validity the
terms "diagnostic sensitivity" and "diagnostic specific·
ity" are introduced which represent conditional prob-
abilities. The great practical advantage of this concept
is that it allows the physician to choose an examina-
tion method corresponding to the question to be
answered. In the phase of hypothesis formation when
making a diagnosis, he will choose äs "search test" a
sensitive test, but in the confirmation phase he will
choose instead a specific test with high proof value
äs the "confirmation test".
A completely different approach for solving the val-
idation problem originates from the signal detection
theory which tackles the detection of a signal in the
presence of noise (75, 76). The essential Instrument is
the "receiver operating characteristic curve" (ROC),
which represents the frequency of the "hits", i. e. the
"true positive" results, in dependence upon the fre-
quency of the "false alarms", i. e. the "falsely positive"
results (fig. 9). A practical advantage is to be seen in
the possibility of defining the Optimum setting of the
tests, which can be achieved by shifting the decision
limits.
A third approach proceeds from the consideration
that the diagnostic examination provides the physi-
cian with Information. Information is defined in the
















Sensitivity = P ( T I D )
Specfficity = P ( T I D )
Optimum Operation point
1.0,
0.2 0.4 0.6 0.8 1.0
P ( T | D )
Fig. 9. Receiver operating characteristic.
Explanation: D = diseased, D = not diseased,
T = test result positive.
Conditional probabilities are denoted äs P (X | Y)
(probability of X given ).
Fig. 8. Validation of a dichotomic test.
Explanation: D = diseased, D = not diseased,
T = test result positive, T = test result negative.
theory of Information (77-^79) äs the eliminatiön of
uncertainty, for example by reeeption of a message.
Messages on rare events have a higher Information
content than those on frequent events. The informa-?
tiön entropy, a logarithmic fimction of the eVent prob-
abilities, furnishes a quantitative measure of the in-
formation. A diagnostic test may now be represented
äs a model in the form of a communication channel
(fig. 10). The Information gained by the test, the so-
called transinformation 7, can be calculated äs entropy
difference and used äs a mqasure of quality for the
test (fig. 11). The advantage of the Information theory
approach lies in the extensive independence from any
assumption on the nature and distribution of the data.
That completes our consideration of these examples,
intended to indicate ways of validating diagnostic
investigations on the nosological level. It must höw-
ever be pointed out that the validation methods avail·-
able at present cannot be applied withoüt cafefül
study to all investigation methods. Particular prob-
lems are presented by quantitative investigations. The
procedure usüally adopted there is to classify the
results using a decision limit, thus transfornaing the
quantitative test to a qualitative test with dichotomic
outcome.
Finally, in table 5 the methods discussed for vaÜdating
laboratory examinations and laböratory fiüdings will
be sümmarized once again. A distinction is made here
between overall measures, with which the examination
methods can be checked in general, and specific meas-
ures which can be applied to yalidate the individual
laboratory findings. * i
Bur. J. Clin. Chem. GHn. Biochem. / VpL 29,1991 / Nö. 8
Büttner: Laboratory findings in medical cognitive processes 517






Information theoretical modelof a lest
• Information entropy H (D)
·· Information entropy H (DI T)
Uncertalnty betöre the test
on existing disease






Fig. 10. Information theoretical model of a test.
Explanation: Entropies H (X) and conditional entro-
pies H(X\Y) are given in a notation similar to the
probabilities (see fig. 8).
Equlvocation
H(D\T)
(0, ) TransInformation I(D;T) fH(T)
l
Ambiguity
Test capacity C = max [H ( D ) + H ( T) - H ( D,T)]
Transinformation / (D\T) = H(D)-H(D\T] - H ( T \ D )
Fig. 11. Transinformation of a test (Berger diagram).
Explanation: Entropies H (X) and conditional entro-
pies H(X\Y) are given in a notation similar to the
probabilities (see fig. 8).
Conclusion
This investigation was undertaken with the objective
of developing and precisely defining the concept of
medical laboratory findings. In medicine, usually only
vague ideas exist about the structure, formation and
mental processing of laboratory findings. This made
an exact analysis from the point of view of the phi-
losophy of science and semiotics appear desirable.
Such an analysis may help the clinician and the clinical











































chemist to better understanding of the theoretical
basis of laboratory findings and their validity. More-
over it could be the basis for the development of
effective expert Systems. Any diagnostic System based
on "artificial intelligence" must reconstruct the cog-
nitive processes which result in a diagnosis. The struc-
ture of the scientific language used to describe the
laboratory finding and the logic deductions should be
reproduced correctly by the expert System.
Our investigation has shown that laboratory findings
are observation sentences which describe an object
property. They are expressed in a relatively highly
formalised and metrised scientific language. Labora-
tory findings obtain their "meaning" in a multistage
prpcess of signification, which has been analysed in
detail. Through this process laboratory findings be-
come signs symbolizing or indicating a significatum,
for example a morbus. The use of these signs was
studied by way of example with reference to the
processes of making a diagnosis and prognosis.
Finally, the numerous possibilities of uncertainties in
these signs arising during the process of singification
were considered. Some methods of validating and
checking have been outlined.
In ciosing, it is pointed out that the theoretical anal-
ysis dealt with here was restricted to the example of
the laboratory finding made by an experimental ex-
amination using methods of analytical chemistry. The
structure of such laboratory findings is relatively sim-
ple. Further investigation is necessary to determine
whether the results of other medical investigation
methods may be dealt with in a similar way.
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